Sun Pharmaceutical Industries Share Price
1899.60-16.40 (-0.86%)
+20.33% past 1 Year
Sun Pharmaceutical Industries Limited is among the largest specialty generic pharmaceutical company and India's top pharmaceutical company. A vertically integrated business and a skilled team enables it to deliver high-quality
Corporate filings & documents
Announcements
Intimation of Schedule of Analyst/Institutional Investor Meeting
23 hours agoIntimation of Schedule of Analyst/Institutional Investor Meeting
23 hours agoSun Pharma participates in White House Signing Ceremony highlighting U.S. Medicines Pricing and Access Commitments
3 days agoNewspaper Advertisements about Postal Ballot/E-voting
1 week agoNewspaper Advertisements about Postal Ballot/E-voting
1 week agoNotice of Postal Ballot/E-voting
1 week agoNotice of Postal Ballot/E-voting
1 week agoIntimation of Schedule of Analyst/Institutional Investor Meeting
1 week agoIntimation of Schedule of Analyst/Institutional Investor Meeting
1 week agoUpdate on Lipitor Antitrust Litigation
2 weeks agoUpdate on Lipitor Antitrust Litigation
2 weeks agoReceipt of No-objection letters from the Stock Exchanges for Reclassification of Promoter Group
4 weeks agoReceipt of No-objection letters from the Stock Exchanges for Reclassification of Promoter Group
4 weeks agoQ1FY27 Earnings Call Transcript
4 weeks agoQ1FY27 Earnings Call Transcript
4 weeks agoIntimation of Schedule of Analyst/Institutional Investor Meeting
4 weeks agoIntimation of Schedule of Analyst/Institutional Investor Meeting
4 weeks agoUpdate on Credit Rating
1 month agoUpdate on Credit Rating
1 month agoNewspaper Advertisement
1 month agoNewspaper Advertisement
1 month agoVoting Results for 34th AGM
1 month agoVoting Results for 34th AGM
1 month agoOutcome of the 34th Annual General Meeting held on 31 July 2026
1 month agoOutcome of the 34th Annual General Meeting held on 31 July 2026
1 month agoSPIL Q1FY27-Investor Call Audio Recording
1 month agoSPIL Q1FY27-Investor Call Audio Recording
1 month agoConclusion of the Board Meeting held today
1 month agoConclusion of the Board Meeting held today
1 month agoQuarterly Financial Results for Q1 of FY 2026-27
1 month agoQuarterly Financial Results for Q1 of FY 2026-27
1 month agoSun Pharma receives approval to manufacture and market semaglutide in Brazil
1 month agoSun Pharma receives approval to manufacture and market semaglutide in Brazil
1 month agoNewspaper advertisement about opening of Special Window for transfer of physical shares
1 month agoNewspaper advertisement about opening of Special Window for transfer of physical shares
1 month agoUpdate on Nidlegy
1 month agoUpdate on Nidlegy
1 month agoSun Pharma notes Organon Shareholder approval for proposed acquisition
1 month agoSun Pharma notes Organon Shareholder approval for proposed acquisition
1 month agoPress Release
1 month agoPress Release
1 month agoSun Pharma to announce first quarter results on 31 July 2026Earnings call scheduled on Friday 06.30 pm IST 31 July 2026
1 month agoSun Pharma to announce first quarter results on 31 July 2026Earnings call scheduled on Friday 06.30 pm IST 31 July 2026
1 month agoSun Pharmaceutical Industries Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 31/07/2026 inter alia to consider and approve Unaudited Standalone and Consolidated Financial Results for the quarter ended 30 June 2026
1 month agoSun Pharmaceutical Industries Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 31/07/2026 inter alia to consider and approve Unaudited Standalone and Consolidated Financial Results for the quarter ended 30 June 2026
1 month agoInvestor Presentation -June 2026
1 month agoInvestor Presentation -June 2026
1 month agoNewspaper Publication
1 month agoNewspaper Publication
1 month agoSubmission of Confirmation Certificate for the quarter ended 30 June 2026.
1 month agoConcalls & investor presentations
Jul 2026
ConcallPresentation
Apr 2026
ConcallPresentation
Jan 2026
Nov 2025
ConcallPresentation
Jul 2025
ConcallPresentation
May 2025
Jan 2025
Oct 2024
Aug 2024
May 2024
Jan 2024
Nov 2023
ConcallPresentation
Aug 2023
May 2023
Jan 2023
ConcallPresentation
Nov 2022
Jul 2022
May 2022
ConcallPresentation
Jan 2022
Nov 2021
ConcallPresentation
Jul 2021
ConcallPresentation
May 2021
Jan 2021
ConcallPresentation
Nov 2020
ConcallPresentation
Corporate Actions
Date
Type
Details
2026-07-07
Dividend
5.0
2026-02-05
Dividend
11.0
2026-02-05
Dividend
11
2025-07-07
Dividend
5.5
2025-02-06
Dividend
10.5
2024-07-12
Dividend
5.0
2024-02-09
Dividend
8.5
2023-07-28
Dividend
4.0
2023-02-08
Dividend
7.5
2022-08-19
Dividend
3.0
2022-02-09
Dividend
7.0
2021-08-23
Dividend
2.0
2021-02-09
Dividend
5.5
2020-08-19
Dividend
1.0
2020-02-17
Dividend
3.0
2019-08-20
Dividend
2.75
2018-09-17
Dividend
2.0
2017-09-18
Dividend
3.5
2016-09-08
Dividend
1.0
2015-10-21
Dividend
3.0
2014-09-11
Dividend
1.5
2013-09-19
Dividend
2.5
2013-07-29
Bonus
1:1
2012-08-14
Dividend
4.25
2011-09-02
Dividend
3.5
2010-11-25
Split
5:1
2010-09-09
Dividend
13.75
Company details
Registered office
Sun Pharma Advanced Research Centre (S P A R C) Tandalja Vadodara Gujarat PIN: 390012 Tel No: 0265- 5515500 / 5515600 / 5515700 Fax No: 0265- 2354897 Email: [email protected] Internet: www.sunpharma.com
Registrars
C 101, 247 Park, LBS Marg, Vikhroli (W), Mumbai(Old Address:) C-13 Pannalal Silk Compound, L B S Marg, Bhandup Mumbai Maharashtra C 101, 247 Park LBS Marg Vikhroli (West) PIN: Tel No: +91 810 811 8484 Fax No: 91-022-49186060 Email: [email protected] Internet: https://in.mpms.mufg.com/
Management
Anoop Deshpande, Company Secretary & Compliance Officer
Dilip Shantilal Shanghvi, Chairman
Kirti Ganorkar, Managing Director
Gautam Doshi, Non Executive Independent Director
Rolf Hoffmann, Non Executive Independent Director
Aalok Shanghvi, Whole Time Director & Chief Operating Officer
Pawan Goenka, Lead Independent Director
Satyavati Berera, Non Executive Independent Director
Vidhi Shanghvi, Whole Time Director & Head - CHC
Andreas Eugen Busch, Non Executive Independent Director
Details
BSE 524715
NSE SUNPHARMA
ISIN INE044A01036